Shylaja Srinivasan

Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Lori M. Laffel, Thomas Danne, Georgeanna J. Klingensmith et al. · The Lancet Diabetes & Endocrinology · 2023 · 98 citations · Full text

Metabolic Syndrome, Diabetes Management, Young People +11

Introduction and Methodology: Standards of Care in Diabetes—2025

Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo et al. · Diabetes Care · 2024 · 97 citations · Full text

Diabetes Management, Diabetes Epidemiology, Health Policy +4

The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium

Shylaja Srinivasan, Ling Chen, Jennifer N. Todd et al. · Diabetes · 2021 · 76 citations · Full text

The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes

Sheela N. Magge, Risa M. Wolf, Laura Pyle et al. · The Journal of Pediatrics · 2022 · 65 citations · Full text

Youth-onset Type 2, Coronavirus Disease 2019, Diabetes Epidemiology +10

<i>TCF7L2</i> Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)

Shylaja Srinivasan, Varinderpal Kaur, Bindu Chamarthi et al. · Diabetes Care · 2018 · 44 citations · Full text